FDA Announces Recall of Common Blood Pressure Medication - Health: Trusted and Empathetic Health and Wellness Information
Inventia Healthcare Limited voluntarily recalled more than 11,000 bottles of 25-milligram chlorthalidone tablets. A manufacturing defect may prevent the medication from dissolving properly in the body. This issue could make the blood pressure drug ineffective.
What changed
Additional reports confirm the recall is occurring nationwide across the US.
Live updates
-
FDA Recalls Over 11,000 Bottles of Chlorthalidone Blood Pressure Medication
confidence 100%Inventia Healthcare Limited voluntarily recalled more than 11,000 bottles of 25-milligram chlorthalidone tablets. A manufacturing defect may prevent the medication from dissolving properly in the body. This issue could make the blood pressure drug ineffective.
What's confirmed:
- Inventia Healthcare Limited voluntarily recalled more than 11,000 bottles of 25-milligram chlorthalidone tablets.
- The recall involves a manufacturing defect that may reduce how well the medicine dissolves and works.
- The recalled blood pressure medication was sold nationwide.
-
FDA Announces Nationwide Recall of Chlorthalidone Blood Pressure Medication
confidence 100%Inventia Healthcare Limited has voluntarily recalled more than 11,000 bottles of 25-milligram chlorthalidone tablets. The recall stems from a manufacturing issue where tablets may not dissolve properly in the body. This failure to meet dissolution specifications could render the medication ineffective.
What's confirmed:
- Inventia Healthcare Limited voluntarily recalled 25-milligram tablets of chlorthalidone.
- More than 11,000 bottles of the blood pressure medication were recalled nationwide.
- The recall is due to a manufacturing issue where tablets may not dissolve properly.
- The medication failed to meet dissolution specifications.
Still unconfirmed:
- An Indian company is voluntarily recalling the medication.